In a personal essay for PEOPLE, TikTok star Eldiara Doucette opens up about her recurring soft tissue cancer, losing her ...

Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.

Despite concerns over cabozantinib's patent expiry, Exelixis projects robust future revenues, with lead pipeline candidate zanzalintinib showing potential to offset future revenue losses.

When the BIOSECURE Act hit a setback and missed the chance of becoming law in 2024, the deceleration of the draft legislation ...

A study has found targeting a protein called endocan and its related signaling pathway could be a promising new approach for treating glioblastoma, an aggressive and lethal type of brain cancer.

AI-supported mammography screening significantly increases breast cancer detection rates while maintaining comparable recall ...

The thyroid gland's health can significantly impact metabolism and growth. Recognizing signs such as a persistent neck lump, ...

You might have a change of heart today and feel like bailing on social plans at the eleventh hour. Chalk it up to a meeting between your ruler, the moon, and impromptu Uranus in your collective ...

The last time New Mexico United was on the pitch, it was the coach on the other sideline who walked off victorious. Now, he’s ...

You can keep up with the latest episodes by subscribing to our Big Picture in Practice Newsletter. 144% advisor business growth is no joke. Hyper-growth like that stems from advisor practices that ...

Manager Aziz Hamzaogullari thinks and acts like a long-term investor. His team's "alpha thesis" (or its view of what gives it an edge over the competition) is sound in principle. It holds that ...